{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-103726","form_type":"8-K","ticker":"DFTX","cik":"0001813814","company_name":"Definium Therapeutics, Inc.","filed_at":"2025-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.557418+00:00","generated_at":"2026-05-17T01:42:17.980055+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"MindMed reports preliminary cash ~$209.1M as of Sep 30, 2025","bullets":["Preliminary cash, cash equivalents and investments total approximately $209.1M as of September 30, 2025.","Data is unaudited and subject to KPMG review; may differ from final Q3 figures.","Filed a prospectus supplement and posted an updated corporate presentation on October 29, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-103726","json":"https://secwatch.observer/filing/0001104659-25-103726.json","markdown":"https://secwatch.observer/filing/0001104659-25-103726.md","text":"https://secwatch.observer/filing/0001104659-25-103726.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1813814/000110465925103726/0001104659-25-103726-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1813814/000110465925103726/tm2529652d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:42:17.980055+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}